vs

Side-by-side financial comparison of CareTrust REIT, Inc. (CTRE) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.

CareTrust REIT, Inc. is the larger business by last-quarter revenue ($134.9M vs $76.2M, roughly 1.8× VIEMED HEALTHCARE, INC.). CareTrust REIT, Inc. runs the higher net margin — 82.5% vs 7.4%, a 75.1% gap on every dollar of revenue. On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs 25.5%). Over the past eight quarters, CareTrust REIT, Inc.'s revenue compounded faster (46.2% CAGR vs 22.7%).

Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.

CTRE vs VMD — Head-to-Head

Bigger by revenue
CTRE
CTRE
1.8× larger
CTRE
$134.9M
$76.2M
VMD
Growing faster (revenue YoY)
CTRE
CTRE
+29.6% gap
CTRE
55.1%
25.5%
VMD
Higher net margin
CTRE
CTRE
75.1% more per $
CTRE
82.5%
7.4%
VMD
Faster 2-yr revenue CAGR
CTRE
CTRE
Annualised
CTRE
46.2%
22.7%
VMD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTRE
CTRE
VMD
VMD
Revenue
$134.9M
$76.2M
Net Profit
$111.3M
$5.6M
Gross Margin
57.9%
Operating Margin
11.0%
Net Margin
82.5%
7.4%
Revenue YoY
55.1%
25.5%
Net Profit YoY
113.5%
30.7%
EPS (diluted)
$0.52
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTRE
CTRE
VMD
VMD
Q4 25
$134.9M
$76.2M
Q3 25
$132.4M
$71.9M
Q2 25
$112.5M
$63.1M
Q1 25
$96.6M
$59.1M
Q4 24
$86.9M
$60.7M
Q3 24
$77.4M
$58.0M
Q2 24
$68.9M
$55.0M
Q1 24
$63.1M
$50.6M
Net Profit
CTRE
CTRE
VMD
VMD
Q4 25
$111.3M
$5.6M
Q3 25
$74.9M
$3.5M
Q2 25
$68.5M
$3.2M
Q1 25
$65.8M
$2.6M
Q4 24
$52.1M
$4.3M
Q3 24
$33.4M
$3.9M
Q2 24
$10.8M
$1.5M
Q1 24
$28.7M
$1.6M
Gross Margin
CTRE
CTRE
VMD
VMD
Q4 25
57.9%
Q3 25
57.5%
Q2 25
58.3%
Q1 25
56.3%
Q4 24
59.5%
Q3 24
59.3%
Q2 24
59.8%
Q1 24
58.9%
Operating Margin
CTRE
CTRE
VMD
VMD
Q4 25
11.0%
Q3 25
58.1%
7.8%
Q2 25
61.3%
8.1%
Q1 25
6.5%
Q4 24
10.6%
Q3 24
43.0%
9.7%
Q2 24
15.1%
6.6%
Q1 24
4.4%
Net Margin
CTRE
CTRE
VMD
VMD
Q4 25
82.5%
7.4%
Q3 25
56.6%
4.9%
Q2 25
60.9%
5.0%
Q1 25
68.1%
4.4%
Q4 24
60.0%
7.1%
Q3 24
43.2%
6.7%
Q2 24
15.6%
2.7%
Q1 24
45.6%
3.2%
EPS (diluted)
CTRE
CTRE
VMD
VMD
Q4 25
$0.52
$0.14
Q3 25
$0.35
$0.09
Q2 25
$0.35
$0.08
Q1 25
$0.35
$0.06
Q4 24
$0.30
$0.10
Q3 24
$0.21
$0.10
Q2 24
$0.07
$0.04
Q1 24
$0.22
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTRE
CTRE
VMD
VMD
Cash + ST InvestmentsLiquidity on hand
$198.0M
$13.5M
Total DebtLower is stronger
$894.2M
Stockholders' EquityBook value
$4.0B
$141.5M
Total Assets
$5.1B
$199.2M
Debt / EquityLower = less leverage
0.22×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTRE
CTRE
VMD
VMD
Q4 25
$198.0M
$13.5M
Q3 25
$712.5M
$11.1M
Q2 25
$306.1M
$20.0M
Q1 25
$26.5M
$10.2M
Q4 24
$213.8M
$17.5M
Q3 24
$377.1M
$11.3M
Q2 24
$495.1M
$8.8M
Q1 24
$451.2M
$7.3M
Total Debt
CTRE
CTRE
VMD
VMD
Q4 25
$894.2M
Q3 25
$893.8M
Q2 25
$1.2B
Q1 25
$822.1M
Q4 24
$396.9M
Q3 24
$396.7M
Q2 24
$671.1M
Q1 24
$595.9M
Stockholders' Equity
CTRE
CTRE
VMD
VMD
Q4 25
$4.0B
$141.5M
Q3 25
$4.0B
$133.6M
Q2 25
$3.3B
$139.7M
Q1 25
$2.9B
$134.8M
Q4 24
$2.9B
$131.4M
Q3 24
$2.4B
$125.0M
Q2 24
$1.9B
$119.4M
Q1 24
$1.7B
$116.3M
Total Assets
CTRE
CTRE
VMD
VMD
Q4 25
$5.1B
$199.2M
Q3 25
$5.1B
$202.4M
Q2 25
$4.7B
$184.6M
Q1 25
$3.9B
$178.1M
Q4 24
$3.4B
$177.1M
Q3 24
$2.9B
$169.5M
Q2 24
$2.7B
$163.9M
Q1 24
$2.3B
$154.9M
Debt / Equity
CTRE
CTRE
VMD
VMD
Q4 25
0.22×
Q3 25
0.22×
Q2 25
0.35×
Q1 25
0.28×
Q4 24
0.14×
Q3 24
0.16×
Q2 24
0.35×
Q1 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTRE
CTRE
VMD
VMD
Operating Cash FlowLast quarter
$394.0M
$18.4M
Free Cash FlowOCF − Capex
$9.7M
FCF MarginFCF / Revenue
12.7%
Capex IntensityCapex / Revenue
11.5%
Cash ConversionOCF / Net Profit
3.54×
3.27×
TTM Free Cash FlowTrailing 4 quarters
$11.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTRE
CTRE
VMD
VMD
Q4 25
$394.0M
$18.4M
Q3 25
$100.9M
$18.4M
Q2 25
$100.8M
$12.3M
Q1 25
$71.4M
$2.9M
Q4 24
$244.3M
$15.0M
Q3 24
$67.2M
$12.7M
Q2 24
$53.0M
$10.2M
Q1 24
$48.8M
$1.2M
Free Cash Flow
CTRE
CTRE
VMD
VMD
Q4 25
$9.7M
Q3 25
$10.7M
Q2 25
$4.1M
Q1 25
$-12.6M
Q4 24
$3.2M
Q3 24
$1.7M
Q2 24
$1.2M
Q1 24
$-4.8M
FCF Margin
CTRE
CTRE
VMD
VMD
Q4 25
12.7%
Q3 25
14.9%
Q2 25
6.5%
Q1 25
-21.4%
Q4 24
5.2%
Q3 24
3.0%
Q2 24
2.3%
Q1 24
-9.5%
Capex Intensity
CTRE
CTRE
VMD
VMD
Q4 25
11.5%
Q3 25
10.6%
Q2 25
12.9%
Q1 25
26.2%
Q4 24
19.5%
Q3 24
19.0%
Q2 24
16.3%
Q1 24
11.9%
Cash Conversion
CTRE
CTRE
VMD
VMD
Q4 25
3.54×
3.27×
Q3 25
1.35×
5.23×
Q2 25
1.47×
3.88×
Q1 25
1.08×
1.09×
Q4 24
4.68×
3.47×
Q3 24
2.01×
3.29×
Q2 24
4.92×
6.94×
Q1 24
1.70×
0.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons